Anpac Bio-Medical Science ADR (ANPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANPC | MRNA | BMY | AMGN | GILD |
| Company | Anpac Bio-Medical Science ADR | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 4.57 | 107.43 | 47.39 | 273.45 | 67.47 |
| High | 4.65 | 108.23 | 47.50 | 274.35 | 67.90 |
| Low | 4.25 | 103.52 | 44.56 | 267.24 | 65.32 |
| Last | 4.37 | 105.14 | 44.46 | 269.14 | 65.35 |
| Change | -0.25 | -3.71 | -4.40 | -3.87 | -1.73 |
| % Change | -5.41% | -3.41% | -9.01% | -1.42% | -2.58% |
| Volume | 35,700 | 1,596,773 | 27,054,519 | 724,299 | 5,526,243 |
| 20-Day Average Volume | 29,135 | 3,075,423 | 11,879,533 | 2,092,540 | 6,350,908 |
| Previous Close | 4.62 | 108.85 | 48.86 | 273.01 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.67 | 104.93 | 49.94 | 270.70 | 68.70 |
| 20-Day Raw Stochastic | 3.61% | 41.72% | 2.03% | 31.27% | 3.45% |
| 20-Day Relative Strength | 40.18% | 51.51% | 28.54% | 44.82% | 29.12% |
| Weighted Alpha | -31.90 | -12.90 | -34.52 | +9.13 | -23.17 |
| Today's Opinion | 40% Sell | 88% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 40% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 24% Sell | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.16% since 05/12/23 | +2.82% since 04/18/24 | -7.23% since 04/18/24 | +2.53% since 04/18/24 | -0.82% since 04/18/24 |
| Low | 4.19 on 05/16/23 | 99.30 on 04/22/24 | 44.61 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 5.75 on 05/15/23 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 |
| 1-Month | |||||
| %Chg | -4.17% since 04/19/23 | -4.98% since 03/25/24 | -14.24% since 03/25/24 | -4.07% since 03/25/24 | -9.60% since 03/25/24 |
| Low | 4.19 on 05/16/23 | 97.00 on 04/03/24 | 44.61 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 9.17 on 05/02/23 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -52.86% since 02/17/23 | +2.01% since 01/25/24 | -9.68% since 01/25/24 | -13.17% since 01/25/24 | -18.22% since 01/25/24 |
| Low | 3.49 on 04/13/23 | 84.06 on 02/13/24 | 44.61 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 9.19 on 02/21/23 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | +12.92% since 11/18/22 | +36.63% since 10/25/23 | -20.84% since 10/25/23 | -1.01% since 10/25/23 | -16.30% since 10/25/23 |
| Low | 3.02 on 11/22/22 | 62.55 on 11/02/23 | 44.61 on 04/25/24 | 249.70 on 10/31/23 | 65.32 on 04/25/24 |
| High | 11.99 on 01/19/23 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,234 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
| Shares Outstanding, K | 969 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 1,750,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -14,770,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 437,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -31,904,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.56 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 12/19/22 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/30/23 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.53 | 14.67 | 9.97 |